Background
In 1979, Azzopardi described intraepithelial neoplasia which he called "clinging carcinoma in situ". 1 She regarded the lesion as a variant of DCIS (ductal carcinoma in situ), which is easy * Corresponding author at: 15 Garbary St., 61-866 Poznan, Poland. Tel.: +48 618850600; fax: +48 618850601.
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to overlook in histopathology, and is due to cellular rather than architectural changes. Currently, FEA is the earliest, morphologically recognizable neoplastic lesion in the breast. It is characterized by medium to large cellular atypia epithelial single layer of cells. The degree of cellular atypia should be a determinant of the division of FEA into 2 groups -a high [4] [5] [6] [7] [8] The most common radiographic presence of FEA are microcalcifications. 9 They occur in approximately 74% of patients with FEA. 10 Observed ultrasound, they present a poorly demarcated nodular mass with irregular shape, sometimes with arched or spicular border. 9 The aim of this study is to evaluate the underestimation of invasive lesions after the initial diagnosis of FEA in mammotome vacuum core biopsy.
Materials and methods
Retrospectively analyzed 20 patients with a primary diagnosis of FEA on the basis of mammotome vacuum assisted 11 gauge core needle biopsies. A biopsy was performed in the mammtome biopsy outpatient clinic in the Department of Surgical Oncology and General Surgery, Wielkopolska Cancer Centre. For six and a half years, 4326 biopsies were done. Biopsies were performed in patients with nonpalpable breast lesions. In other cases, ultrasound-guided core needle biopsies were performed (this group of patients is not the subject of the present study). Mammotome biopsy was performed on the table, where patients were turned to face downwards (Fisher Imaging, Denver, CO, USA) using 11 gauge directional vacuum assisted biopsy systems (Mammotome Biopsy/Ethicon EndoSurgery, Cinncinatti, OH). They obtained an average of 12 cores (from 7 to 30). Biopsies were performed by three oncological surgeons. In most cases, patients were referred with a suspicious mammogram image detected in a nationwide screening program. Patients with diagnosis of FEA were treated surgically by excision of the area where FEA was diagnosed. In the case of finding the cancer re-excision if no clear margins were found was performed together with sentinel node biopsy for axillary nodal staging. For all cases, pictures and descriptions of mammography, or ultrasound data were collected for review ( Figs. 1 and 2 ). The patients were re-examined and verified for clinical data such as age, oncological history, family burden, mammography, concomitant benign lesions of the breast, type of operation.
Results
Among 20 patients with FEA diagnosis a mean age was 59. 
Discussion
Discovering suspected microcalcifications detected at screening mammography leads to diagnosis by stereotactic core needle biopsy. Currently, we can use stereotactic or ultrasoundguided core needle biopsy for many different breast lesions. 10, 11 In case of the FEA, cancerous lesions of the breast should be searched. In addition to problems related to the very procedure of biopsy, destruction of specimens and a small amount of tissue collected at biopsy, we must also handle with its twisting, or crushing. All this makes it difficult to adequately assess results of histopathological examination.
Owing to the use of thicker biopsy needles (11 G instead of 14 G), greater number of biopsy fragments retrieved, and the routine use of radiographs of collected tissue fragments, the accuracy of microscopic examination has improved. There are still no clear guidelines for the diagnosis of FEA in the stereotactic biopsy. In only a few studies in small numbers of patients lesions of invasive and preinvasive pattern occurred in 13-30% of cases. 8,12-17 DCIS and LN (lobular neoplasia) were present along with FEA in 22-36% of cases. 18 In the study by Guerra-Wallace et al. describing the frequency of coexistence of tumor diagnosis in the case of intraductal hyperplasia (Columnare cell lesions) on the basis of core biopsy, the final excision was followed by a higher incidence of tumor in the group with atypia (FEA-11/60-18%) compared to patients without atypia -(UDH 10/135-7%). 14 The report by Bonnet et al., nine cases with FEA were found in 167 biopsies. Of these patients, two were detected to have DCIS, and three ADH (atypical ductal hyperplasia) after radical surgery. 12 In the paper by Kunju and Kleer, out of 14 patients diagnosed with FEA in core biopsy (14 G), after surgical excision of the lesion, one was found to show concomitant DCIS, and in two cases invasive cancers were detected. 8 Underestimation of invasive lesions amounted to 21%. It should also be noted that in other five cases (36%) ADH was found, and LN and in one case (8%). Usability testing of Ki-67 has been demonstrated as negative, because regardless of whether additional clusters were found cancerous or not, the results were similar. 15 It is important to demonstrate the presence of chronic inflammation (29%) and stromal changes (36%), such as myxoid changes and periductal fibrosis, which are associated with FEA. The study by Piubello et al. reported 875 patients who underwent core biopsy (11 G). 33 cases were diagnosed with FEA. 17 None of these patients showed concomitant cancer after surgical excision. However, in the case of coexistent FEA and ADH found in 11 patients, underestimation of cancer was 30%. In the study by Chivukula et al. on a group of 35 patients diagnosed with FEA, underestimation of the tumor was 14%, while in the presence of FEA together with ADH underestimation was 16.3%. 13 There was no statistical significance between the underestimation of cancer in the group with FEA, FEA + ADH and ADH alone. 13 In the study by Lim et al. on five patients with CCL and atypia, in one (20%) DCIS lesion were found after surgical excision. 19 Labbe-DeVilliers et al. described two subgroups of patients: CCH with atypia -25 cases, CCC with atypia -15 patients. 20 Invasive lesions were diagnosed in 4 patients (10%), and DCIS in 3 (8%), accounting for a total underestimation of the tumor of 18%. All tumors were found in the group of CCH with atypia. If the CCC with atypia in mammography images outbreak was less than 10 mm, there was no concomitant cancer changes. In the study by de Mascarel et al. on the basis of 2833 biopsies due to suspected microcalcifications, FEA was found in 101 patients. 21 Underestimation of the tumor occurred in 17 of them (17%). Among the concomitant cancers were 12 cases of DCIS or invasive ductal cancer, four cases of tubular cancer and one of lobular carcinoma. In our study, FEA was diagnosed in 20 patients, representing 0.5% of all cases diagnosed in the mammotome biopsy. Studies with a percent of underestimation in the case of FEA diagnosis are summarized in Table 1 . [4] [5] [6] [7] [8] The reason for this finding in our population is unclear, but probably can be accounted for by a small number of patients diagnosed with FEA. The question of eligibility of patients for radical removal of the lesion remains unresolved. Does the complete removal of microcalcifications due to core biopsy eliminate the need for surgical resection of the area? Will greater amount of tissue collected during biopsy allow for close observation of patients, instead of surgery? According to Ho et al., even total resection of an area of microcalcifications in the case of ADH is associated with a 17% underestimation of invasive cancer. 7 In the case of FEA, the risk may be the same. Magnetic resonance might be a useful tool in diagnosis of premalignant lesions. But additional research is required on the usefulness of this test. We should also consider better information for the patient as well as support, especially in the case of increased risk of breast, cancer in the future. 22 
